1. Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study.
- Author
-
Hsiang E, Patel K, Wilson EC, Dunham A, Ikeda J, Matheson T, and Santos GM
- Subjects
- Humans, Male, Adult, Middle Aged, Motivation, Interviews as Topic, Sexual and Gender Minorities psychology, Social Stigma, Health Services Accessibility, Cocaine-Related Disorders therapy, Qualitative Research, Homosexuality, Male psychology, Medication Adherence
- Abstract
Background: Rates of cocaine use disorder (CUD) among men who have sex with men (MSM) are high and rising. Among MSM, cocaine use is associated with negative socioeconomic, medical, and psychological outcomes. There are no FDA-approved pharmacotherapy options to treat CUD, and psychosocial interventions demonstrate limited efficacy. While there have been numerous trials evaluating possible medications for CUD, there is a scarcity of qualitative data on the barriers and facilitators of medication-assisted treatment., Methods: Semi-structured interviews were conducted with 16 participants enrolled in a phase II randomized control trial evaluating extended-release lorcaserin among MSM with CUD. Participants were asked about their motivations for enrolling in the study, attitudes towards taking a medication for CUD, barriers and facilitators of study pill adherence, and their general study experience. Interviews were analyzed using an inductive and exploratory approach to thematic analysis., Results: Participants were highly motivated to reduce cocaine use and viewed pharmacotherapy as a viable and desirable treatment option. Pharmacotherapy was seen as having fewer access and adherence structural barriers compared to existing psychosocial therapies. Medication reminders facilitated pill taking, while side effects, travel, and active substance use presented barriers to study pill adherence. Disclosure of study participation within social networks was variable pointing to anticipated substance use and treatment stigma., Conclusions: Our study highlights important factors affecting the acceptability and uptake of medication-assisted treatment for CUD among a diverse sample of MSM. These findings can help guide the development and implementation of future pharmacotherapy options for CUD and other substance use disorders in this key population., Competing Interests: Declarations. Ethics approval and consent to participate: This study was approved by the Institutional Review Board at the University of California, San Francisco (#17-21502). All participants provided written consent to participate. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF